Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1999 2
2000 3
2001 4
2002 1
2004 1
2005 1
2007 1
2008 3
2009 2
2011 1
2012 2
2013 2
2014 1
2015 1
2017 1
2019 2
2020 4
2021 4
2022 4
2023 9
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Grymonprez M, Carnoy L, Capiau A, Boussery K, Mehuys E, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Among authors: de backer tl. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):722-730. doi: 10.1093/ehjcvp/pvad070. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37791408
Propionyl-L-carnitine for intermittent claudication.
Kamoen V, Vander Stichele R, Campens L, De Bacquer D, Van Bortel L, de Backer TL. Kamoen V, et al. Among authors: de backer tl. Cochrane Database Syst Rev. 2021 Dec 26;12(12):CD010117. doi: 10.1002/14651858.CD010117.pub2. Cochrane Database Syst Rev. 2021. PMID: 34954832 Free PMC article. Review.
Naftidrofuryl for intermittent claudication.
de Backer TL, Vander Stichele R, Lehert P, Van Bortel L. de Backer TL, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001368. doi: 10.1002/14651858.CD001368.pub4. Cochrane Database Syst Rev. 2012. PMID: 23235580 Free PMC article. Review.
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.
Grymonprez M, Capiau A, Steurbaut S, Boussery K, Mehuys E, Somers A, Petrovic M, De Backer TL, Lahousse L. Grymonprez M, et al. Among authors: de backer tl. Cardiovasc Drugs Ther. 2023 Nov 6. doi: 10.1007/s10557-023-07521-5. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37930588
Buflomedil for intermittent claudication.
de Backer TL, Vander Stichele R. de Backer TL, et al. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD000988. doi: 10.1002/14651858.CD000988.pub4. Cochrane Database Syst Rev. 2013. PMID: 23543509 Free PMC article. Review.
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
Grymonprez M, Vanspranghe K, Steurbaut S, De Backer TL, Lahousse L. Grymonprez M, et al. Among authors: de backer tl. Cardiovasc Drugs Ther. 2023 Aug;37(4):781-791. doi: 10.1007/s10557-021-07279-8. Epub 2021 Oct 12. Cardiovasc Drugs Ther. 2023. PMID: 34637052 Review.
49 results